PREDICTING COMPLETE CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT INTERFERON-ALPHA

被引:0
|
作者
MAHON, FX
MONTASTRUC, M
FABERES, C
REIFFERS, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3592 / 3594
页数:3
相关论文
共 50 条
  • [31] HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA
    TALPAZ, M
    KANTARJIAN, HM
    MCCREDIE, K
    TRUJILLO, JM
    KEATING, MJ
    GUTTERMAN, JU
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (17): : 1065 - 1069
  • [32] Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy
    Kantarjian, HM
    Giles, FJ
    O'Brien, SM
    Talpaz, M
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (01) : 31 - +
  • [33] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    GEORGII, A
    BARTRAM, CR
    GRIESSHAMMER, M
    BERGMANN, L
    ESSERS, U
    FALGE, C
    QUEISSER, U
    MEYER, P
    SCHMITZ, N
    EIMERMACHER, H
    WALTHER, F
    FETT, W
    KLEEBERG, UR
    KABISCH, A
    NERL, C
    ZIMMERMANN, R
    MEURET, G
    TICHELLI, A
    KANZ, L
    TIGGES, FJ
    SCHMID, L
    BROCKHAUS, W
    TOBLER, A
    REITER, A
    PERKER, M
    EMMERICH, B
    VERPOORT, K
    ZANKOVICH, R
    VONWUSSOW, P
    PRUMMER, O
    THIELE, J
    BUHR, T
    CARBONELL, F
    ANSARI, H
    BLOOD, 1994, 84 (12) : 4064 - 4077
  • [34] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    BLOOD, 1999, 94 (10) : 279B - 279B
  • [35] Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
    Kataoka, I
    Shinagawa, K
    Shiro, Y
    Okamoto, S
    Watanabe, R
    Mori, T
    Ito, D
    Harada, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (02) : 149 - 153
  • [36] High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia
    Mahon, FX
    Faberes, C
    Montastruc, M
    SiMour, S
    Boiron, JM
    Marit, G
    BilhouNabera, C
    ConyMakhoul, P
    Pigneux, A
    Bernard, P
    Broustet, A
    Reiffers, J
    BONE MARROW TRANSPLANTATION, 1996, 17 : S33 - S37
  • [37] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases
    L Fayad
    H Kantarjian
    S O’Brien
    D Seong
    M Albitar
    M Keating
    M Talpaz
    Leukemia, 1997, 11 : 767 - 771
  • [38] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases
    Fayad, L
    Kantarjian, H
    OBrien, S
    Seong, D
    Albitar, M
    Keating, M
    Talpaz, M
    LEUKEMIA, 1997, 11 (05) : 767 - 771
  • [39] ENDOGENOUS LYMPHOKINE ACTIVATED KILLER-CELL ACTIVITY AND CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH ALPHA-INTERFERON
    MESERI, A
    DELWAIL, V
    BRIZARD, A
    LECRON, JC
    PELLETIER, D
    GUILHOT, F
    TANZER, J
    GOUBEDELALAFOREST, P
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 783 - 783
  • [40] ENDOGENOUS LYMPHOKINE ACTIVATED KILLER-CELL ACTIVITY AND CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH ALPHA-INTERFERON
    MESERI, A
    DELWAIL, V
    BRIZARD, A
    LECRON, JC
    PELLETIER, D
    GUILHOT, F
    TANZER, J
    DELAFOREST, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (02) : 218 - 222